| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: MIPI |
| Security Type |
Common Stock |
| Lead Underwriter |
RBC Capital Markets Jefferies & Co Inc |
| Days In Registration |
450 |
| Date Filed |
8-Nov-2005 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Molecular Insight Pharmaceuticals Inc, located in Cambridge, Massachusetts, manufactures prescription pharmaceuticals intended for final consumption, including biotech products and antibiotics. The company was incorporated in the Commonwealth of Massachusetts in 1997 under the name Imaging Biopharmaceuticals, Inc. and subsequently changed its name to Biostream, Inc. in 1998, and subsequently changed its name again to Molecular Insight Pharmaceuticals, Inc. in 2003. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
24.64M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
5.0M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
5.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
750.0K |
| File Amount |
$75.0M |
| File Price Range |
$16.00 - $14.00 |
| File Mid Price |
$15.00 |
Current Filing Information
(Amended 30-Jan-2007) |
|
US |
|
Shares Filed |
5.0M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
5.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$75.0M |
| · % Change from Original |
0.0 |
| File Price Range |
$16.00 - $14.00 |
| File Mid Price |
$15.00 |
|
